Home > Category > Signaling Pathways > Protein Tyrosine Kinase/RTK > c-Met/HGFR > Rilotumumab (Anti-HGF / SF)

Rilotumumab (Anti-HGF / SF)

ChemLeader 95+%
Catalog No:CLA1225 CAS No.:872514-65-3 MDLNo: Formula: MW:
Size Availability Price(USD) VIP Price (USD) Quantity
1 mg 3-5days $720.00 Visible after login
- +
5 mg 3-5days $1800.00 Visible after login
- +
10 mg 3-5days $2900.00 Visible after login
- +
50 mg 3-5days $12000.00 Visible after login
- +
100 mg 3-5days $18000.00 Visible after login
- +

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Rilotumumab (Anti-HGF / SF)
CAS872514-65-3
Storage conditionStore at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light.
Product details

Rilotumumab (AMG 102) is a monoclonal antibody targeting hepatocyte growth factor that inhibits HGF/ MET-driven signaling. Rilotumumab has antitumor effects and can be used to study castration-resistant prostate cancer (CRPC) and gastric cancer.

Related literature
Sorry, there is no relevant literature
Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays